Cheek filler face-off: new contender matches market leader
NCT ID NCT07162610
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new dermal filler (Rejuviel V with lidocaine) works as well as an existing one (JUVEDERM VOLUMA with lidocaine) for temporarily adding volume to the mid-face area, including the cheeks. 89 Korean adults with moderate to severe volume loss received injections in both sides of the face. The goal was to see if the new filler is non-inferior in improving cheek fullness at 24 weeks, while also checking safety. Both fillers are designed to be temporary and do not cure any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MID FACE VOLUME DEFICIT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chung-Ang University Hospital
Soeul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.